Pharmacology News

Updates on beta-blocker use, revascularization and routine testing and recommendations on healthy lifestyle are among the highlights of a new guideline on the management of patients with chronic coronary disease.

Winter-induced elevations in BP were persistent among patients with hypertension despite treatment with up to three classes of antihypertensive medications, with an approximately 7% drop in BP control, researchers reported.

In 2021, unintentional opioid toxicity was attributed to one in 22 deaths among all adults and one in 10 deaths among those aged 15 to 19 years, a recent study found.

Statin use for primary prevention was associated with reduced risk for all-cause and CV death among patients with hypertension and no other CVD or diabetes vs. matched controls not on statin therapy, researchers reported.

Mark Cuban Cost Plus Drug Company’s pricing could yield significant savings for seven generic oncology drugs vs. Medicare Part D median formulary prices, according to study results published in Journal of Clinical Oncology.

The FDA has granted Eisai full approval for Leqembi to treat adults with Alzheimer’s disease.

In a trial of more than 20,000 older adults, vitamin D supplementation trended toward reducing risk for major CV events in older adults compared with placebo, a finding differing from previous studies.

Interventions based on Choosing Wisely guidelines significantly reduced rates of antibiotic prescriptions for acute respiratory tract infections at safety-net hospitals participating in a pay-for-performance program, researchers found.

A first-of-its kind drug demonstrated potential as a safe and effective treatment for cannabis use disorder, according to a phase 2a study published in Nature Medicine.

Members of the AMA adopted new policies on substance use during its annual meeting of the House of Delegates, according to a press release.